 |
Corporate News |
| |
|
Dr Reddy’s Q1FY27: Net Profit declines 69% YoY, impacted by Rs 239 crore semaglutide provisions
23-Jul-2026
Pharma major Dr Reddy’s Laboratories posted its Q1FY27 net profit at Rs 443.5 crore, declining 69% year-on-year from Rs 1,417.8 crore reported in Q1FY26. However, on a sequential basis, its consolidated net profit surged 97% from Rs 220.5 crore reported in the trailing quarter.
The pharma company reported its consolidated revenue from operations at Rs 8,070.5 crore, down 5.5% from Rs 8,545.2 crore posted in the year-ago period. Sequentially, the revenue jumped 7.3% from Rs 7,516. 2 crore reported in Q4FY26.
News Source:- https://www.financialexpress.com/business/industry/dr-reddys-q1fy27-net-profit-declines-69-yoy-impacted-by-rs-239-crore-nbspsemaglutide-provisionsnbsp/4299449/
|
|
| |
| |
| |
 |
Notes:
1. Copyright and ownership of all content from IMC and other IMC sites belongs to IMC except third-party resources
2. Copyright, intellectual property right, ownership or responsibility of error of other content belong to respective sources
3. Please do not reply to this mail
For suggestions and feedback click here.
Disclaimer:
IMC is not responsible for any kind of loss arising due to the information. You are receiving this newsletter because you have subscribed to this service. To unsubscribe click here.
Head Office :
IMC Bldg., IMC Marg,
Churchgate, Mumbai - 400 020 India | Tel : 91-22-22046633 | Fax : 91-22-22048508 / 22838281
E-Mail : imc@imcnet.org | Website : www.imcnet.org |
| |
| |
|